Symptomatic Efficacy of Etanercept and Its Effects on Objective Signs of Inflammation in Early Nonradiographic Axial Spondyloarthritis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Maxime Dougados; Désirée van der Heijde; Joachim Sieper; Jürgen Braun; Walter P. Maksymowych; Gustavo Citera; Corinne Miceli-Richard; James Cheng-Chung Wei; Ron Pedersen; Randi Bonin; Mahboob U. Rahman; Isabelle Logeart; Joseph Wajdula; Andrew S. Koenig; Bonnie Vlahos; Daniel Alvarez; Jack F. Bukowski

doi:10.1002/art.38721

Symptomatic Efficacy of Etanercept and Its Effects on Objective Signs of Inflammation in Early Nonradiographic Axial Spondyloarthritis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Arthritis & Rheumatology ◽

10.1002/art.38721 ◽

2014 ◽

Vol 66 (8) ◽

pp. 2091-2102 ◽

Cited By ~ 121

Author(s):

Maxime Dougados ◽

Désirée van der Heijde ◽

Joachim Sieper ◽

Jürgen Braun ◽

Walter P. Maksymowych ◽

...

Keyword(s):

Axial Spondyloarthritis ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Nonradiographic Axial Spondyloarthritis

Download Full-text

Faculty Opinions recommendation of Efficacy and Safety of Ixekizumab in the Treatment of Radiographic Axial Spondyloarthritis: Sixteen-Week Results From a Phase III Randomized, Double-Blind, Placebo-Controlled Trial in Patients With Prior Inadequate Response to or Intolerance of Tumor Necrosis Factor Inhibitors.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.734268130.793576219 ◽

2020 ◽

Author(s):

Pedro Machado

Keyword(s):

Tumor Necrosis ◽

Axial Spondyloarthritis ◽

Controlled Trial ◽

Phase Iii ◽

Inadequate Response ◽

Tumor Necrosis Factor Inhibitors ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Necrosis Factor

Download Full-text

SAT0350 Quality of Life with Etanercept in Early Non-Radiographic Axial Spondyloarthritis: 24 and 48-Week Data from A Randomized, Double-Blind, Placebo-Controlled Trial

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2014-eular.2242 ◽

2014 ◽

Vol 73 (Suppl 2) ◽

pp. 719.2-719

Author(s):

J. Sieper ◽

E. Drescher ◽

J. Rosa ◽

R. Pedersen ◽

R. Bonin ◽

...

Keyword(s):

Quality Of Life ◽

Axial Spondyloarthritis ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

OP0108 Clinical and Imaging Efficacy of Etanercept in Early Non-Radiographic Axial Spondyloarthritis: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2013-eular.313 ◽

2013 ◽

Vol 72 (Suppl 3) ◽

pp. A87.2-A88 ◽

Cited By ~ 9

Author(s):

M. Dougados ◽

D. van der Heijde ◽

J. Sieper ◽

J. Braun ◽

W. P. Maksymowych ◽

...

Keyword(s):

Axial Spondyloarthritis ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

A Randomized, Double‐Blind, Placebo‐Controlled, Sixteen‐Week Study of Subcutaneous Golimumab in Patients With Active Nonradiographic Axial Spondyloarthritis

Arthritis & Rheumatology ◽

10.1002/art.39257 ◽

2015 ◽

Vol 67 (10) ◽

pp. 2702-2712 ◽

Cited By ~ 110

Author(s):

J. Sieper ◽

D. van der Heijde ◽

M. Dougados ◽

W. P. Maksymowych ◽

B. B. Scott ◽

...

Keyword(s):

Axial Spondyloarthritis ◽

Double Blind ◽

Double Blind Placebo ◽

Nonradiographic Axial Spondyloarthritis

Download Full-text

THU0238 A Randomized, Double-Blind, Placebo-Controlled, 16-Week Study of Subcutaneous Golimumab in Patients with Active Nonradiographic Axial Spondyloarthritis

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2015-eular.1214 ◽

2015 ◽

Vol 74 (Suppl 2) ◽

pp. 283.1-283 ◽

Cited By ~ 1

Author(s):

J. Sieper ◽

D. van der Heijde ◽

M. Dougados ◽

W.P. Maksymowych ◽

J.A. Boice ◽

...

Keyword(s):

Axial Spondyloarthritis ◽

Double Blind ◽

Double Blind Placebo ◽

Nonradiographic Axial Spondyloarthritis

Download Full-text

THU0366 Efficacy of Adalimumab in Patients with Axial Spondyloarthritis: Results of an Investigator-Initiated 12-Weeks Randomized Double-Blind Placebo Controlled Trial with a 12 Weeks Open-Label Extension Phase

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2013-eular.894 ◽

2013 ◽

Vol 72 (Suppl 3) ◽

pp. A289.2-A289 ◽

Cited By ~ 1

Author(s):

S. J. Pedersen ◽

IJ Sørensen ◽

AG Loft ◽

JS Hindrup ◽

G Thamsborg ◽

...

Keyword(s):

Axial Spondyloarthritis ◽

Controlled Trial ◽

Extension Phase ◽

Open Label ◽

Double Blind ◽

Double Blind Placebo ◽

Open Label Extension

Download Full-text

Efficacy and Safety of Ixekizumab in the Treatment of Radiographic Axial Spondyloarthritis: Sixteen‐Week Results From a Phase III Randomized, Double‐Blind, Placebo‐Controlled Trial in Patients With Prior Inadequate Response to or Intolerance of Tumor Necrosis Factor Inhibitors

Arthritis & Rheumatology ◽

10.1002/art.40753 ◽

2019 ◽

Vol 71 (4) ◽

pp. 599-611 ◽

Cited By ~ 54

Author(s):

Atul Deodhar ◽

Denis Poddubnyy ◽

Cesar Pacheco‐Tena ◽

Carlo Salvarani ◽

Eric Lespessailles ◽

...

Keyword(s):

Tumor Necrosis ◽

Axial Spondyloarthritis ◽

Controlled Trial ◽

Phase Iii ◽

Inadequate Response ◽

Tumor Necrosis Factor Inhibitors ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Necrosis Factor

Download Full-text

Clinical efficacy of specific immunotherapy to cat dander: a double-blind placebo-controlled trial

Clinical & Experimental Allergy ◽

10.1046/j.1365-2222.1997.1220903.x ◽

1997 ◽

Vol 27 (8) ◽

pp. 860-867 ◽

Cited By ~ 11

Author(s):

V.A. VARNEY ◽

J. EDWARDS ◽

K. TABBAH ◽

H. BREWSTER ◽

G. MAVROLEON ◽

...

Keyword(s):

Clinical Efficacy ◽

Specific Immunotherapy ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

A randomized double blind, placebo controlled trial of a Chinese herbal preparation (CH100) in chronic Hepatitis C

Gastroenterology ◽

10.1016/s0016-5085(01)81907-7 ◽

2001 ◽

Vol 120 (5) ◽

pp. A384-A384

Author(s):

L MOLLISON ◽

L TOTTEN ◽

C HOVELL ◽

K THAYNE ◽

C CONNELLY ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Controlled Trial ◽

Herbal Preparation ◽

Double Blind ◽

Double Blind Placebo ◽

Chinese Herbal

Download Full-text

Patients with non-cardiac chest pain (NCCP) recelving an empirical trial of high dose lansoprazole, demonstrate early symptom response. A double blind, placebo-controlled trial

Gastroenterology ◽

10.1016/s0016-5085(01)81101-x ◽

2001 ◽

Vol 120 (5) ◽

pp. A221-A221 ◽

Cited By ~ 6

Author(s):

R FASS ◽

G PULLIAM ◽

C HAYDEN

Keyword(s):

Chest Pain ◽

Controlled Trial ◽

High Dose ◽

Double Blind ◽

Early Symptom ◽

Double Blind Placebo ◽

Symptom Response

Download Full-text